Этиология и патогенез цервикальных интраэпителиальных неоплазий (обзор зарубежной литературы)
https://doi.org/10.21518/2079-701X-2015-17-149-150
Аннотация
Цервикальные интраэпителиальные неоплазии (CIN) представляют собой атипическую трансформацию плоскоклеточного эпителия без инвазии в строму и являются предикторами рака шейки матки. Согласно классификации Всемирной организации здравоохранения (2014) выделяют низкую степень эпителиального поражения шейки матки (CIN I; легкая дисплазия; плоская кондилома; койло-цитоз; койлоцитарная атипия) и высокую степень эпителиального поражения (CIN II-III; средняя и тяжелая дисплазии; эпителиальная карцинома in situ) [45].
Об авторах
С. А. Леваков
Первый Московский государственный медицинский университет им. И.М. Сеченова
Россия
Россия
Н. А. Шешукова
Первый Московский государственный медицинский университет им. И.М. Сеченова
Россия
Россия
Л. С. Дабагян
Первый Московский государственный медицинский университет им. И.М. Сеченова
Россия
Россия
Список литературы
1. Ahdieh-Grant L, Li R, Levine AM et al. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2004. 96. 1070-1076.
2. Beyrer C, Sullivan P, Sanchez J. The increase in global HIV epidemics in MSM. AIDS. 2013. 27(17). 2665-78.
3. Cai 0, Lv L, Shao 0. Human papillomavirus early proteins and apoptosis. Arch Gynecol Obstet. 2013. 287(3). 541-8.
4. Cao S, Gan Y, Dong X. Herpes simplex virus type 2 and the risk of cervical cancer: a meta-analysis of observational studies. Arch Gynecol Obstet. 2014. 290(6). 1059-66.
5. Chatterjee A, Rathore A, Vidyan S et al. Chemokines and chemokine receptors in susceptibility to HIV-1 infection and progression to AIDS. Dis Markers. 2012. 32. 143-51.
6. Cibula D, Gompel A, Mueck AO et al. Hormonal contraception and risk of cancer. Hum Reprod Update. 2010. 16. 631-650.
7. Clifford GM, Polesel J, Rickenbach M et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005. 97. 425-432.
8. Cosgrove C, Ussher JE, Rauch A et al. Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. Blood. 2013. 121. 951-61.
9. Crosbie EJ, Kitchener HC. Human papillomavi-rus as a target for management, prevention and therapy. Int J Hyperthermia. 2012. 28(6). 478-88.
10. Denslow SA, Rositch AF, Firnhaber C. Incidence and progression of cervical lesions in women with HIV: a systematic global review. Int J STD AIDS. 2014. 25(3). 163-77.
11. Dillner J. Prevention of human papillomavirus-associated cancers. Semin Oncol. 2015. 42(2). 272-83.
12. Dugue PA, Rebolj M, Garred P. Immunosuppression and risk of cervical cancer. Expert Rev Anticancer Ther. 2013. 13(1). 29-42.
13. Evans MF, Adamson CS, Papillo JL. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer. 2006. 106(5). 1054-64.
14. Firnhaber C. Michelow P. Cervical cancer and the human immunodeficiency virus: a review. South African J HIV Med. 2009. 10. 23-27.
15. Gadducci A. Barsotti C, Cosio S. Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature. Gynecol Endocrinol. 2011. 27(8). 597-604.
16. Garrett LA, McCann CK. Abnormal cytology in 2012: management of atypical squamous cells, low-grade intraepithelial neoplasia, and high-grade intraepithelial neoplasia. Clin Obstet Gynecol. 2013. 56(1). 25-34.
17. Gavric-Lovrec V, Takac I. Use of various contraceptives and human papillomavirus 16 and 18 infections in women with cervical intraepithe-lial neoplasia. Int J STD AIDS. 2010. 21. 424427.
18. Ghittoni R, Accardi R, Hasan U. The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes. 2010. 40(1). 1-13.
19. Gokhale P, Mania-Pramanik J, Sonawani A. Cervical cancer in Indian women reveals contrasting association among common sub-family of HLA class I alleles. Immunogenetics. 2014. 66(12). 683-91.
20. Govindappagari S, Schiavone M.B, Wright J.D. Cervical neoplasia. Clin Obstet Gynecol. 2011. 54(4). 528-36.
21. Hosono S, Kawase T, Matsuo K et al. HLA-A alleles and the risk of cervical squamous cell carcinoma in Japanese women. J Epidemiol. 2010. 20. 295-301.
22. Kojima S, Kawana K, Tomio K. The prevalence of cervical regulatory T cells in HPV-related cervical intraepithelial neoplasia (CIN) correlates inversely with spontaneous regression of CIN. Am J Reprod Immunol. 2013. 69(2). 134-41.
23. Lagunas-Martinez A, Madrid-Marina V, Gariglio P. Modulation of apoptosis by early human papillomavirus proteins in cervical cancer. Biochim Biophys Acta. 2010. 1805(1). 6-16.
24. Li C, Wu M, Wang J. A population-based study on the risks of cervical lesion and human pap-illomavirus Infection among women in Beijing, People's Republic of China. Cancer Epidemiol Biomarkers Prev. 2010. 19. 2655-2564.
25. Manzo-Merino J, Thomas M, Fuentes-Gonzalez A.M. HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers. Expert Opin Ther Targets. 2013. 17(11). 1357-68.
26. Marks M, Gravitt P, Gupta S. et al. The association of hormonal contraceptive use and HPV prevalence. Int J Cancer. 2011. 51. 341-352.
27. Matsumoto K, Oki A, Furuta R. et al. Tobacco smoking and regression of low-grade cervical abnormalities. Cancer Sci. 2010. 101. 20652073.
28. Matsumoto K, Yoshikawa H. Human papilloma-virus infection and the risk of cervical cancer in Japan. J Obstet Gynaecol Res. 2013. 39(1). 7-17.
29. Miranda LN, Reginaldo FP, Souza DM. Greater expression of the human leukocyte antigen-G (HLA-G) and interleukin-17 (IL-17) in cervical intraepithelial neoplasia: analytical cross-sectional study. Sao Paulo Med J. 2014. 28. 48-51.
30. Munger K, Jones D.L. Human papillomavirus carcinogenesis: an identity crisis in the retino-blastoma tumor suppressor pathway. J Virol. 2015. 89(9). 4708-11.
31. Pantanowitz L, Michelow P. Review of human immunodeficiency virus (HIV) and squamous lesions of the uterine cervix. Diagn Cytopathol. 2011. 39(1). 65-72.
32. Roman A, Munger K. The papillomavirus E7 proteins. Virology. 2013. 445(1-2). 138-68.
33. Roura E, Castellsague X, Pawlita M. Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. Int J Cancer. 2014. 135(2). 453-66.
34. Ruttkay-Nedecky B, Jimenez Jimenez A.M. Relevance of infection with human papilloma-virus: the role of the p53 tumor suppressor protein and E6/E7 zinc finger proteins (Review). Int J Oncol. 2013. 43(6). 1754-62.
35. Sanad A.S, Kamel H.H, Hasan M.M. Prevalence of cervical intraepithelial neoplasia (CIN) in patients attending Minia Maternity University Hospital. Arch Gynecol Obstet. 2014. 289(6). 1211-7.
36. Sherman ME, Schiffman M, Cox J.T. Atypical Squamous Cells of Undetermined Significance/ Low-Grade Squamous Intraepithelial Lesion Triage Study Group. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst. 2002. 94(2). 102-7.
37. Thorsteinsson K, Ladelund S, Jensen-Fangel S. Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general population. HIV Med. 2015. 8. 223-245.
38. Ting J, Rositch A.F, Taylor S.M. Worldwide incidence of cervical lesions: a systematic review. Epidemiol Infect. 2015. 143(2). 225-41.
39. Tjalma WA, Van Waes TR, Van den Eeden LE et al. Role of human papillomavirus in the car-cinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Pract Res Clin Obstet Gynaecol. 2005. 19. 469-483.
40. Tomkins A, White C, Higgins S.P. Primary herpes simplex virus infection mimicking cervical cancer. BMJ Case Rep. - 2015. 2. 20-35.
41. Tommasino M. The human papillomavirus family and its role in carcinogenesis. Semin Cancer Biol. 2014. 26. 13-21.
42. Tonon SA, Picconi MA, Bos PD. Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions. J Clin Virol. 2001. 21(2). 129-34.
43. Vessey M, Yeates D, Flynn S. Factors affecting mortality in a large cohort study with special reference to oral contraceptive use. Contraception. 2010. 82. 221-229.
44. White EA, Howley PM. Proteomic approaches to the study of papillomavirus-host interactions. Virology. 2013. 435(1). 57-69.
45. WHO Classufication of Tumours of Female Reproductive Organs Edited by R.J.Kurman, M.L.Carcangiu, C.S.Herrington, R.H.Young.- 2014
46. Yamada R, Sasagawa T, Kirumbi L.W. Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection. J Med Virol. - 2008. 80. 847-855.
47. Zhao Y, Cao X, Zheng Y. Relationship between cervical disease and infection with human papillomavirus types 16 and 18, and herpes simplex virus 1 and 2. J Med Virol. 2012. 84(12). 1920-7.
Рецензия
Для цитирования:
Леваков СА, Шешукова НА, Дабагян ЛС. Этиология и патогенез цервикальных интраэпителиальных неоплазий (обзор зарубежной литературы). Медицинский Совет. 2015;(17):149-150. https://doi.org/10.21518/2079-701X-2015-17-149-150
For citation:
Levakov SA, Sheshukova NA, Dabagyan LS. Etiology and pathogenesis of cervical intraepithelial neoplasia (review of foreign literature). Meditsinskiy sovet = Medical Council. 2015;(17):149-150. (In Russ.) https://doi.org/10.21518/2079-701X-2015-17-149-150
Просмотров: 411
Послать статью по эл. почте 